Navis Wealth Advisors LLC Buys 2,100 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Navis Wealth Advisors LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 87.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,500 shares of the exchange traded fund’s stock after acquiring an additional 2,100 shares during the quarter. Navis Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $405,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. FMR LLC grew its position in SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after buying an additional 830 shares during the period. Ameritas Advisory Services LLC lifted its holdings in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock valued at $962,000 after purchasing an additional 1,137 shares in the last quarter. Beaton Management Co. Inc. purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $212,000. Robinson Value Management Ltd. lifted its holdings in SPDR S&P Biotech ETF by 1.2% during the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after purchasing an additional 155 shares in the last quarter. Finally, Granite Bay Wealth Management LLC lifted its holdings in SPDR S&P Biotech ETF by 4,965.8% during the second quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock valued at $11,097,000 after purchasing an additional 121,613 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $92.46 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a market capitalization of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. The firm’s 50 day simple moving average is $93.34 and its two-hundred day simple moving average is $96.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.